Influence of heredity on human sensitivity to environmental chemicals

Environmental and Molecular Mutagenesis

Volumn 25, Issue 2 S, 1995, Pages 102-114

  Weber, Wendell W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

genetic variation; heredity; receptor proteins

Indexed keywords

ENVIRONMENTAL CHEMICAL; EPOXIDE; PARATHION; RECEPTOR PROTEIN; RETINOIC ACID;

CARCINOGENESIS; DRUG METABOLISM; DRUG RESISTANCE; GENETIC VARIABILITY; HEREDITY; HUMAN; MUTAGENICITY; PHARMACOGENETICS; REVIEW;

CARCINOGENS, ENVIRONMENTAL; ENVIRONMENTAL POLLUTANTS; ENZYMES; GENETIC DISEASES, INBORN; HUMAN; PHARMACOGENETICS; SUPPORT, U.S. GOV'T, P.H.S.; VARIATION (GENETICS);

EID: 0029052296     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.2850250614     Document Type: Article

References (97)

1. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: Glutamine or arginine at position 191, for the respective A or B allozymes
2. Deficient N‐oxidation of nicotine in two sisters with trimethylaminuria
3. Genetic polymorphism of trimethylamine N‐oxidation
4. Trinucleotide repeat expansions and human genetic disease
5. Tamoxifen withdrawal response
6. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen‐metabolism gene glutathione S‐transferase M1 (GSTMI) that increases susceptibility to bladder cancer
7. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa
8. Hereditary aspects of malignant hyperthemia
9. Genetic heterogeneity of the human glutathione transferases: A complex of gene families
10. CYPIA2‐catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans
11. An enzyme from rat liver catalyzing conjugations with glutathione
12. Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion
13. Role of N‐acetyltransferase phenotype in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
14. Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid‐induced leukemia cell differentiation
15. Occurrence of distinct PML‐RAR‐α fusion gene isoforms in patients with acute promyelocytic leukemia detected by reverse transcriptase/polymerase chain reaction
16. Rearrangements of the retinoic acid receptor alpha and promyelocytic zinc finger genes resulting from t( 11:17)(q23:q21) in a patient with acute promyelocytic leukemia
17. The retinoic acid alpha receptor gene is frequently disrupted in its 5′ part in Chinese patients with acute promyelocytic leukemia
18. The molecular basis of leukemia
19. Cystic fibrosis: Molecular biology and therapeutic implications
20. Altered chloride ion channel kinetics associated with the Δ508 cystic fibrosis mutation
21. Anesthetic deaths in a family
22. The PML‐RARα fusion in acute promyelocytic leukemia encodes a functionally altered RAR.
23. Evidence for genetic heterogeneity of malignant hyperthermia susceptibility
24. Chloride conductance expressed by Δ508 and other mutant CFTRs in Xenopus oocytes
25. Heterozygous missense mutation in the rhodopsin gene is a cause of congenital stationary night blindness
26. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts
27. The human serum paraoxonase/arylesterase polymorphism
28. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia
29. Genetisch determinierter Polymorphismus der menschlichen Serum‐Paraoxonase (EC 3.1.1.2
30. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia
31. Active site‐directed inactivation of constitutively active mutants of rhodopsin
32. Detection of a new polymorphism of human arylamine N‐acetyltransferase NATI using p‐aminosalicyclic as an in vivo probe
33. Human cytochrome P450 enzymes
34. Decoding at the ribosomal A site: antibiotics, misreading and energy of aminoacyl‐tRNA binding
35. Genetic aspects of antibiotic induced deafness: mitochondrial inheritance
36. Use of all trans retinoic acid in treatment of acute promyelocytic leukemia
37. The molecular basis of the human serum paraoxonase activity polymorphism
38. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity
39. Chromosomal translocation t( 15:17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
40. Parathion poisoning from contaminated barley
41. Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey ras‐1 gene
42. Increased risk of lung cancer in Japanese smokers with class mu glutathione S‐transferase gene deficiency
43. Human serum paraoxonase/arylesterase
44. Esterases of human tissues
45. Cortisol receptor resistance: The variability of its clinical presentation and response to treatment
46. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins
47. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility
48. A chimaeric 11‐β‐hydroxylase/aldosterone synthase gene causes glucocorticoid‐remediable aldosteronism and human hypertension
49. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
50. Slow acetylator mutation in the human polymorphic N‐acetyltransferase gene in 786 Asians, Blacks, Hispanics, and Whites: Application to metabolic epidemiology
51. Glutathi‐one S‐transferase μ in human lymphocyte and liver: role in modulating formation of carcinogen‐derived DNA adducts
52. The human ryanodine receptor gene: Its mapping to 19q13.1, placement in a chromosome 19 linkage group and exclusion as the gene causing myotonic dystrophy
53. Malignant hypothermia
54. Ryanodine receptor gene as a candidate for predisposition to malignant hyperthermia
55. A mutation of the glucocorticoid receptor in primary cortisol resistance
56. Nomenclature for human glutathione transferases
57. Retinal genetics: a nullifying effect for rhodopsin
58. Androgen resistance caused by mutations in the androgen receptor gene
59. The long QT syndrome: Genetic considerations
60. Polymorphism of the CYPIA1 and glutathione transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population
61. Pharmacogenetics
62. To be or not to be: Immunogenetics and occupational exposure
63. Androgen receptor gene mutations in human prostate cancer
64. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
65. Genetic polymorphism and interethnic variability of plasma paraoxonase activity
66. Biochemical characterization of a pedigree with mitochondrially inherited deafness
67. Mitochondrial ribosomal RNA mutation associated with both antibiotic‐induced and non‐syndromic deafness
68. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2‐amino‐3‐methyl‐imidazo[4,5–f]quinoline (IQ
69. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness
70. Glucocorticoid‐remediable aldosteronism in a large kindred: Clinical spectrum and diagnosis using a characteristic biochemical phenotype
71. HLA‐DPI Glutamate 69: A genetic marker of beryllium disease
72. Constitu‐tively active mutants of rhodopsin
73. Flutamide withdrawal syndrome: its impact on clinical trials in hormone‐refractory prostate cancer
74. 18) in the androgen receptor gene in human prostate cancer
75. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer
76. The trans‐stilbene oxide‐active glutathione transferase in human mononuclear leucocyte is identical with the hepatic glutathione transferase μ
77. Isozyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a followup study
78. Polycyclic aromatic hydrocarbon‐DNA adducts in human lung and cancer susceptibility genes
79. A constitutively activating mutation of the lutetnizing hormone receptor in familial male precocious puberty
80. Estrogen resistance caused by a mutation in the estrogen‐receptor gene in a man
81. Poisoning with organophos‐phorous insecticides
82. Epidemiologic evidence of genetic susceptibility to cancer
83. Parathion poisoning increasing frequency in Finland
84. Structural heterogeneity of Caucasian N‐acetyltransferase at the NATI gene locus
85. Human N‐acetyltransferases
86. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to antiandrogens
87. Antiandrogens and the mutated androgen receptor of LNCaP cells: Differential effects on binding affinity, heat‐shock protein interaction and transcription activation
88. Mitochondrial genetics: A paradigm for aging and degenerative diseases
89. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all trans retinoic acid
90. Individual variability in p‐aminobenzoic acid N‐acetylation by human N‐acetyltransferase (NAT1) of peripheral blood
91. Human glutathione S‐transferase deficiency as a marker of susceptibility to epoxide‐induced cytogenetic damage
92. Relationship between GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer